A double-blind, placebo-controlled, randomized, parallel-group study to evaluate the pharmacokinetics, pharmacodynamics, and safety of single subcutaneous doses of TV-1106 in healthy Japanese and Caucasian subjects

Trial Profile

A double-blind, placebo-controlled, randomized, parallel-group study to evaluate the pharmacokinetics, pharmacodynamics, and safety of single subcutaneous doses of TV-1106 in healthy Japanese and Caucasian subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Albusomatropin (Primary)
  • Indications Somatotropin deficiency
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 04 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top